Edition:
United Kingdom

Foamix Pharmaceuticals Ltd (FOMX.OQ)

FOMX.OQ on NASDAQ Stock Exchange Global Market

5.99USD
15 Dec 2017
Change (% chg)

$0.05 (+0.84%)
Prev Close
$5.94
Open
$5.99
Day's High
$5.99
Day's Low
$5.99
Volume
5,112
Avg. Vol
24,214
52-wk High
$11.26
52-wk Low
$4.03

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 0.80 -0.438
Mar '17 0.93 -0.387
FY 2016 Dec '16 1.49 -0.292
Sep '16 2.54 -0.189
Jun '16 0.75 -0.267
Mar '16 0.75 -0.147
FY 2015 Dec '15 0.27 -0.176
Sep '15 0.02 -0.111
Jun '15 0.11 -0.179
Mar '15 0.45 -0.137
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 2 1.01 1.12 0.90 --
Quarter Ending Mar-18 3 1.10 1.30 0.90 --
Year Ending Dec-17 4 5.23 10.00 3.50 10.01
Year Ending Dec-18 5 6.87 15.00 3.90 23.67
Earnings (per share)
Quarter Ending Dec-17 1 -0.25 -0.25 -0.25 -0.43
Quarter Ending Mar-18 2 -0.35 -0.24 -0.47 --
Year Ending Dec-17 4 -1.51 -0.95 -1.77 -1.48
Year Ending Dec-18 5 -1.45 -1.04 -1.89 -2.14
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 88.66 32.93
P/E High - Last 5 Yrs. -- 290.76 45.62
P/E Low - Last 5 Yrs. -- 93.66 24.34
Beta -- 0.85 0.88
Price to Sales (TTM) 41.95 100.68 5.40
Price to Book (MRQ) 2.39 13.50 5.38
Price to Tangible Book (MRQ) 2.39 13.43 6.78
Price to Cash Flow (TTM) -- 76.24 23.45
% Owned Institutions 58.20 6.25 1.40

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.28 1.52
Dividend 5 Year Growth Rate -- 1.88 5.17
Payout Ratio(TTM) -- 17.26 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 6.12 433.86 9.00
Sales (TTM) vs TTM 1 Yr. Ago 221.69 75.04 5.38
Sales - 5 Yr. Growth Rate -- 33.47 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago -63.89 30.81 19.67
EPS (TTM) vs TTM 1 Yr. Ago -86.23 -- --
EPS - 5 Yr. Growth Rate -- 43.18 10.79
Capital Spending - 5 Yr. Growth Rate -- 40.71 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.68 2.18
Current Ratio (MRQ) 9.03 5.36 2.98
LT Debt to Equity (MRQ) 0.00 18.92 11.56
Total Debt to Equity (MRQ) 0.00 20.59 15.81
Interest Coverage (TTM) -- -112.21 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 99.72 38.73 54.83
Gross Margin - 5 Yr. Avg. -- 51.18 52.40
EBITD Margin (TTM) -833.38 -- --
EBITD - 5 Yr. Avg -- -261.12 15.24
Operating Margin (TTM) -836.30 -556.66 7.76
Operating Margin - 5 Yr. Avg. -- -279.30 10.75
Pre-Tax Margin (TTM) -817.45 -529.90 8.57
Pre-Tax Margin - 5 Yr. Avg. -- -279.03 11.17
Net Profit Margin (TTM) -823.74 -531.35 4.88
Net Profit Margin - 5 Yr. Avg. -- -282.21 7.47
Effective Tax Rate (TTM) -- 23.72 23.11
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 84,632 25,315,636 864,680,397
Net Income/Employee (TTM) -697,147 3,332,197 101,718,341
Receivable Turnover (TTM) 7.42 21.54 5.76
Inventory Turnover (TTM) -- 2.01 3.34
Asset Turnover (TTM) 0.06 0.37 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -46.20 -0.77 11.00
Return on Assets - 5 Yr. Avg. -- -0.26 12.43
Return on Investment (TTM) -49.58 2.36 14.46
Return on Investment - 5 Yr. Avg. -- 2.98 16.28
Return on Equity (TTM) -49.79 2.96 16.05
Return on Equity - 5 Yr. Avg. -- 6.40 17.51
  1 Year 3 Year 5 Year
Sales % 551.00 57.90 --
EPS (TTM) % -55.40 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Foamix Pharmaceuticals Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 57.90%
# of Holders: 57
Total Shares Held: 21,672,774
3 Mo. Net Change: -82,171
# New Positions: 4
# Closed Positions: 16
# Increased Positions: 19
# Reduced Positions: 29
# Net Buyers: -10
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.